Friday, August 15, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

R1 RCM Stock Surges Following Lucrative Acquisition Offer

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Healthcare cloud based
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On February 26, 2024, R1 RCM is seeing a surge in its stock price following a lucrative acquisition offer of $13.75 per share. The company, known for its expertise in revenue cycle management, has garnered a “Moderate Buy” rating from analysts, who have set an average target price of $18.00.

In a recent strategic move, R1 RCM acquired Acclara for a hefty sum of $675 million in cash, along with a warrant allowing the purchase of up to 12.2 million shares of R1 stock at a strike price of $10.52. This acquisition further solidifies R1’s position in the competitive revenue cycle management industry, showcasing the company’s commitment to growth and expansion.

R1 RCM Inc. (RCM) Stock Surges 27.21% on February 26, 2024: Market Analysis

On February 26, 2024, R1 RCM Inc. (RCM) saw a significant increase in its stock performance. According to data from CNN Money, RCM is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating a stable position in the market.

The price of RCM shares experienced a notable increase on this particular day, rising by $3.02 since the previous market close. This represents a substantial 27.21% increase in value, signaling positive momentum for the stock.

RCM opened at $14.05 on February 26th, which was $2.96 higher than its previous closing price. This strong opening suggests that investors were optimistic about the company’s prospects and were willing to pay a premium for RCM shares.

RCM Technologies, Inc. Reports Mixed Financial Results on February 26, 2024: Revenue Up, Net Income Down

On February 26, 2024, RCM Technologies, Inc. (RCM) reported its stock performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $1.81 billion, showing an increase of 22.5% compared to the previous year. However, the total revenue remained flat at $572.80 million for the third quarter.

In terms of net income, RCM reported a net loss of $63.30 million for the past year, which represents a significant decrease of 165.12% compared to the previous year. On the other hand, the net income for the third quarter was $1.30 million, showing an increase of 230.0% since the previous quarter.

Earnings per share (EPS) for RCM were reported at -$0.18 for the past year and $0.00 for the third quarter. This represents an increase of 90.34% in EPS since the previous year and a significant increase of 216.67% since the previous quarter.

Overall, the financial performance of RCM on February 26, 2024, showed mixed results. While the total revenue saw a significant increase compared to the previous year, the net income showed a significant decrease. However, the EPS for the company showed positive growth both year-over-year and quarter-over-quarter.

Investors and analysts will continue to monitor RCM’s financial performance in the coming quarters.

Tags: RCM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Cleanest energy and ev

The Potential of Renewable Energy Integration: Harnessing Electric Vehicles as Grid Assets

Finance_ Charts for stock trading

Truist Securities Analyst Maintains Hold Rating on Main Street Capital with Increased Price Target

Biopharmaceutical Markets and money (1)

FDA Approval of Tevas SIMLANDI A GameChanger in Arthritis Treatment

Recommended

TFF Pharmaceuticals Advancing Respiratory Medicine with Innovative Drug Candidates and Technology Platform

2 years ago
Retail Market Capitalization

Analyst Community Bullish on Academy Sports After Investor Day Presentation

1 year ago

Senior Research Analyst Maintains Buy Rating on Alnylam Pharmaceuticals with Lowered Price Target

1 year ago

Paramount Global Sells Stake in Viacom18 to Reliance Industries

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Intel Stock: Soars on Potential US Government Stake

NKT Holding Stock: Soars on Record Earnings and Upgraded Outlook

Deutsche Euroshop Stock: Mixed Results Amid Recovery Signs

Deere Stock: Cathie Wood Bets Big Amid Market Plunge

Carvana Stock: Major Insider Sales Amid Analyst Optimism

Netease Stock: Mixed Signals Amid Record Gaming Performance

Trending

Finsbury Growth and Income Stock
Stocks

Finsbury Growth and Income Stock: Persistent Discount Sparks Buyback Spree

by Robert Sasse
August 15, 2025
0

Finsbury Growth & Income Trust has intensified its share buyback program, repurchasing an additional 153,246 shares at...

Applied Materials Stock

Applied Materials Stock: Plunges on Grim China Outlook

August 15, 2025
Pandora Stock

Pandora Stock: Resilient Growth Amid Tariff Headwinds

August 15, 2025
Intel Stock

Intel Stock: Soars on Potential US Government Stake

August 15, 2025
NKT Holding Stock

NKT Holding Stock: Soars on Record Earnings and Upgraded Outlook

August 15, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Finsbury Growth and Income Stock: Persistent Discount Sparks Buyback Spree August 15, 2025
  • Applied Materials Stock: Plunges on Grim China Outlook August 15, 2025
  • Pandora Stock: Resilient Growth Amid Tariff Headwinds August 15, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com